Your browser is no longer supported. Please, upgrade your browser.
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E36.64 EPS (ttm)6.65 Insider Own11.30% Shs Outstand907.30M Perf Week2.47%
Market Cap230.70B Forward P/E29.41 EPS next Y8.29 Insider Trans-1.87% Shs Float857.10M Perf Month4.98%
Income6.07B PEG3.36 EPS next Q1.98 Inst Own84.00% Short Float0.75% Perf Quarter0.22%
Sales26.73B P/S8.63 EPS this Y36.90% Inst Trans-0.17% Short Ratio2.54 Perf Half Y30.19%
Book/sh7.10 P/B34.33 EPS next Y4.74% ROA13.10% Target Price271.30 Perf Year72.08%
Cash/sh3.46 P/C70.52 EPS next 5Y10.90% ROE102.00% 52W Range129.21 - 275.87 Perf YTD44.37%
Dividend3.40 P/FCF86.06 EPS past 5Y24.60% ROI22.60% 52W High-11.64% Beta0.29
Dividend %1.39% Quick Ratio0.90 Sales past 5Y4.20% Gross Margin74.30% 52W Low88.65% ATR4.94
Employees35000 Current Ratio1.10 Sales Q/Q22.60% Oper. Margin21.80% RSI (14)59.15 Volatility1.83% 2.15%
OptionableYes Debt/Eq2.56 EPS Q/Q-1.50% Profit Margin22.70% Rel Volume0.77 Prev Close241.17
ShortableYes LT Debt/Eq2.29 EarningsOct 26 BMO Payout47.60% Avg Volume2.53M Price243.75
Recom2.20 SMA204.50% SMA50-0.39% SMA20012.30% Volume1,948,833 Change1.07%
Oct-11-21Upgrade Berenberg Hold → Buy $240 → $270
Sep-29-21Upgrade Citigroup Neutral → Buy $210 → $265
Aug-05-21Upgrade DZ Bank Hold → Buy $288
Jul-27-21Resumed Truist Buy $262
Jun-24-21Reiterated Cantor Fitzgerald Overweight $245 → $300
Jan-19-21Upgrade Mizuho Neutral → Buy $164 → $222
Dec-10-20Upgrade Wolfe Research Peer Perform → Outperform $147 → $183
Nov-10-20Resumed Bernstein Mkt Perform $150
Sep-29-20Initiated Berenberg Hold $144
Sep-03-20Upgrade Morgan Stanley Equal-Weight → Overweight $176
Jun-16-20Upgrade Guggenheim Neutral → Buy
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Oct-23-21 07:01AM  
Oct-22-21 05:50PM  
11:28AM  
06:31AM  
Oct-21-21 01:35PM  
06:53AM  
06:40AM  
Oct-20-21 01:23PM  
08:46AM  
07:10AM  
Oct-19-21 03:02PM  
06:45AM  
Oct-18-21 02:52PM  
11:40AM  
Oct-15-21 05:50PM  
04:30PM  
06:20AM  
04:00AM  
Oct-14-21 01:30PM  
06:30AM  
Oct-13-21 06:45AM  
Oct-12-21 10:00AM  
09:10AM  
Oct-08-21 11:00AM  
Oct-07-21 10:49AM  
09:00AM  
Oct-06-21 04:14PM  
Oct-05-21 08:45AM  
Oct-04-21 01:39PM  
09:00AM  
12:10AM  
12:05AM  
12:00AM  
Oct-01-21 11:18AM  
09:18AM  
09:00AM  
06:47AM  
Sep-30-21 01:52PM  
07:23AM  
05:56AM  
04:40AM  
04:30AM  
Sep-29-21 03:09PM  
10:18AM  
10:00AM  
09:01AM  
08:20AM  
07:36AM  
04:08AM  
Sep-28-21 05:45PM  
11:30AM  
10:08AM  
07:27AM  
06:41AM  
06:30AM  
Sep-27-21 08:00PM  
07:31PM  
08:00AM  
07:53AM  
05:57AM  
Sep-24-21 08:04PM  
07:51PM  
11:30AM  
08:27AM  
Sep-23-21 10:30AM  
Sep-22-21 11:16AM  
Sep-21-21 04:15PM  
02:52PM  
02:09PM  
01:37PM  
10:16AM  
07:00AM  
Sep-20-21 11:44AM  
Sep-19-21 11:01AM  
Sep-17-21 10:11AM  
07:40AM  
Sep-16-21 03:56PM  
03:55PM  
03:30PM  
11:28AM  
Sep-15-21 08:33AM  
07:57AM  
07:38AM  
07:27AM  
06:53AM  
06:45AM  
Sep-13-21 02:52PM  
10:00AM  
08:00AM  
Sep-11-21 06:01AM  
Sep-10-21 01:06PM  
08:12AM  
Sep-09-21 04:42PM  
04:16PM  
02:00PM  
08:00AM  
06:58AM  
Sep-07-21 09:00AM  
06:00AM  
Sep-04-21 11:12AM  
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceuticals worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; and MiNA Therapeutics Limited. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerAug 18Sale274.3115,4304,232,603108,248,610Aug 19 11:35 AM
LILLY ENDOWMENT INC10% OwnerAug 17Sale274.083,060838,698108,264,040Aug 18 01:20 PM
LILLY ENDOWMENT INC10% OwnerAug 09Sale267.50104,71128,010,135108,267,100Aug 10 03:48 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale264.057,5972,005,965108,371,811Aug 09 12:58 PM
LILLY ENDOWMENT INC10% OwnerAug 05Sale264.26132,69235,065,320108,379,408Aug 06 12:57 PM
LILLY ENDOWMENT INC10% OwnerAug 04Sale265.1513,4583,568,360108,512,100Aug 05 03:52 PM
LILLY ENDOWMENT INC10% OwnerAug 03Sale256.12236,54260,582,474108,525,558Aug 04 03:15 PM
LILLY ENDOWMENT INC10% OwnerJul 21Sale237.0086,11120,408,307108,762,100Jul 22 10:47 AM
LILLY ENDOWMENT INC10% OwnerJul 20Sale237.0615,6103,700,429108,848,211Jul 21 11:12 AM
LILLY ENDOWMENT INC10% OwnerJul 14Sale237.0210,7802,555,119108,863,821Jul 15 02:03 PM
LILLY ENDOWMENT INC10% OwnerJul 12Sale237.093,238767,694108,874,601Jul 13 03:08 PM
LILLY ENDOWMENT INC10% OwnerJul 09Sale237.39109,26125,937,091108,877,839Jul 12 12:58 PM
LILLY ENDOWMENT INC10% OwnerJul 06Sale235.09210,00049,369,047108,987,100Jul 07 09:17 AM
LILLY ENDOWMENT INC10% OwnerJul 02Sale232.94202,10247,077,749109,197,100Jul 06 01:05 PM
LILLY ENDOWMENT INC10% OwnerJun 24Sale237.5112,8983,063,401109,399,202Jun 25 01:16 PM
LILLY ENDOWMENT INC10% OwnerJun 10Sale233.63240,00056,072,352109,412,100Jun 11 10:35 AM
LILLY ENDOWMENT INC10% OwnerJun 09Sale224.93220,00049,484,263109,652,100Jun 10 03:35 PM
LILLY ENDOWMENT INC10% OwnerJun 07Sale224.72230,00051,685,008109,872,100Jun 08 03:16 PM
LILLY ENDOWMENT INC10% OwnerMay 24Sale202.277,3291,482,405110,102,100May 25 10:39 AM
LILLY ENDOWMENT INC10% OwnerMay 21Sale200.5892,74018,602,006110,109,429May 24 11:15 AM
LILLY ENDOWMENT INC10% OwnerMay 20Sale200.4899,93120,033,767110,202,169May 21 12:57 PM
TAI JACKSON PDirectorApr 30Buy182.841,366249,75961,195May 03 07:01 PM
Zakrowski Donald AChief Accounting OfficerApr 28Sale181.383,000544,1405,987Apr 29 08:31 PM
LILLY ENDOWMENT INC10% OwnerMar 09Sale209.7959,95912,579,032110,302,100Mar 10 02:59 PM
LILLY ENDOWMENT INC10% OwnerMar 08Sale209.69125,28426,271,092110,362,059Mar 09 12:26 PM
Hakim AnatSVP, GC & SecretaryMar 01Option Exercise0.007,92807,928Mar 03 05:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.005,445027,425Feb 03 06:29 PM
Shah Aarti S.SVP & CIDOFeb 01Option Exercise0.006,282023,369Feb 03 07:02 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0075,3870343,639Feb 03 06:57 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Feb 01Option Exercise0.006,282010,592Feb 03 06:51 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.0012,146056,919Feb 03 06:43 PM
Norton JohnaSenior VP, Global QualityFeb 01Option Exercise0.003,435020,953Feb 03 06:38 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0015,0780115,289Feb 03 06:33 PM
Smiley Joshua LSVP and CFOFeb 01Option Exercise0.0019,266060,702Feb 03 08:22 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,754035,400Feb 03 07:26 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale190.80215,00041,022,862110,487,343Jan 19 01:04 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale185.97210,00039,053,064110,702,343Jan 14 11:23 AM
LILLY ENDOWMENT INC10% OwnerJan 11Sale185.49220,00040,807,754110,912,343Jan 12 11:27 AM